Gut microbiome disruption altered the biotransformation and liver toxicity of arsenic in mice

Abstract

The mammalian gut microbiome (GM) plays a critical role in xenobiotic biotransformation and can profoundly affect the toxic effects of xenobiotics. Previous in vitro studies have demonstrated that gut bacteria have the capability to metabolize arsenic (As); however, the specific roles of the gut microbiota in As metabolism in vivo and the toxic effects of As are largely unknown. Here, we administered sodium arsenite to conventionally raised mice (with normal microbiomes) and GM-disrupted mice with antibiotics to investigate the role of the gut microbiota in As biotransformation and its toxicity. We found that the urinary total As levels of GM-disrupted mice were much higher, but the fecal total As levels were lower, than the levels in the conventionally raised mice. In vitro experiments, in which the GM was incubated with As, also demonstrated that the gut bacteria could adsorb or take up As and thus reduce the free As levels in the culture medium. With the disruption of the gut microbiota, arsenic biotransformation was significantly perturbed. Of note, the urinary monomethylarsonic acid/dimethylarsinic acid ratio, a biomarker of arsenic metabolism and toxicity, was markedly increased. Meanwhile, the expression of genes of one-carbon metabolism, including folr2, bhmt, and mthfr, was downregulated, and the liver S-adenosylmethionine (SAM) levels were significantly decreased in the As-treated GM-disrupted mice only. Moreover, As exposure altered the expression of genes of the p53 signaling pathway, and the expression of multiple genes associated with hepatocellular carcinoma (HCC) was also changed in the As-treated GM-disrupted mice only. Collectively, disruption of the GM enhances the effect of As on one-carbon metabolism, which could in turn affect As biotransformation. GM disruption also increases the toxic effects of As and may increase the risk of As-induced HCC in mice.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

References

  1. Borlak J, Meier T, Halter R, Spanel R, Spanel-Borowski K (2005) Epidermal growth factor-induced hepatocellular carcinoma: gene expression profiles in precursor lesions, early stage and solitary tumours. Oncogene 24(11):1809

    Article  CAS  PubMed  Google Scholar 

  2. Caporaso JG, Lauber CL, Walters WA et al (2012) Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J 6(8):1621

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Chai Z-T, Kong J, Zhu X-D et al (2013) MicroRNA-26a inhibits angiogenesis by down-regulating VEGFA through the PIK3C2α/Akt/HIF-1α pathway in hepatocellular carcinoma. PLoS One 8(10):e77957

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Chen H, Yoshida K, Wanibuchi H, Fukushima S, Inoue Y, Endo G (1996) Methylation and demethylation of dimethylarsinic acid in rats following chronic oral exposure. Appl Organomet Chem 10(9):741–745

    Article  CAS  Google Scholar 

  5. Chen Y, Graziano JH, Parvez F et al (2006) Modification of risk of arsenic-induced skin lesions by sunlight exposure, smoking, and occupational exposures in Bangladesh. Epidemiology 17(4):459–467

    Article  PubMed  Google Scholar 

  6. Chen L, Li Y, Lin CH et al (2013) Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma. Nat Med 19(2):209–216

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Chen J, Liu C, Wen H et al (2014a) Changes in the expression of cyclin G2 in esophageal cancer cell and its significance. Tumor Biol 35(4):3355–3362

    Article  CAS  Google Scholar 

  8. Chen R, Dong Y, Xie X et al (2014b) Screening candidate metastasis-associated genes in three-dimensional HCC spheroids with different metastasis potential. Int J Clin Exp Pathol 7(5):2527

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Chen Y, Qin N, Guo J et al (2014c) Functional gene arrays-based analysis of fecal microbiomes in patients with liver cirrhosis. BMC Genom 15(1):753

    Article  CAS  Google Scholar 

  10. Choi M-G, Noh JH, An JY et al (2009) Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression1. J Surg Res 157(2):168–174

    Article  CAS  PubMed  Google Scholar 

  11. Crandall LZ, Vorce RL (2002) Differential effects of arsenic on folate binding protein 2 (Folbp2) null and wild type fibroblasts. Toxicol Lett 136(1):43–54

    Article  CAS  PubMed  Google Scholar 

  12. Cursiefen C, Chen L, Borges LP et al (2004) VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Investig 113(7):1040

    Article  CAS  PubMed  Google Scholar 

  13. Flora SJ (2011) Arsenic-induced oxidative stress and its reversibility. Free Radic Biol Med 51(2):257–281

    Article  CAS  PubMed  Google Scholar 

  14. Gamble MV, Liu X, Ahsan H et al (2005) Folate, homocysteine, and arsenic metabolism in arsenic-exposed individuals in Bangladesh. Environ Health Perspect 113(12):1683

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Gomez-Marquez J, Segade F, Dosil M, Pichel JG, Bustelo XR, Freire M (1989) The expression of prothymosin alpha gene in T lymphocytes and leukemic lymphoid cells is tied to lymphocyte proliferation. J Biol Chem 264(15):8451–8454

    CAS  PubMed  Google Scholar 

  16. Guerra A, Etienne-Mesmin L, Livrelli V, Denis S, Blanquet-Diot S, Alric M (2012) Relevance and challenges in modeling human gastric and small intestinal digestion. Trends Biotechnol 30(11):591–600

    Article  CAS  PubMed  Google Scholar 

  17. Hamamura N, Macur R, Korf S et al (2009) Linking microbial oxidation of arsenic with detection and phylogenetic analysis of arsenite oxidase genes in diverse geothermal environments. Environ Microbiol 11(2):421–431

    Article  CAS  PubMed  Google Scholar 

  18. Hanna S, Khalil B, Nasrallah A et al (2014) StarD13 is a tumor suppressor in breast cancer that regulates cell motility and invasion. Int J Oncol 44(5):1499–1511

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Hasegawa S, Nagano H, Konno M et al (2015) Cyclin G2: a novel independent prognostic marker in pancreatic cancer. Oncol Lett 10(5):2986–2990

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Haupt S, Berger M, Goldberg Z, Haupt Y (2003) Apoptosis—the p53 network. J Cell Sci 116(20):4077–4085

    Article  CAS  Google Scholar 

  21. Hernández A, Marcos R (2008) Genetic variations associated with interindividual sensitivity in the response to arsenic exposure. Pharmacogenomics 9(8):1113–1132

    Article  CAS  PubMed  Google Scholar 

  22. Hillman B (2004) Role of gut bacteria in human toxicology and pharmacology. CRC Press, Boca Raton, FL

    Google Scholar 

  23. Hirano S, Kobayashi Y, Cui X, Kanno S, Hayakawa T, Shraim A (2004) The accumulation and toxicity of methylated arsenicals in endothelial cells: important roles of thiol compounds. Toxicol Appl Pharmacol 198(3):458–467

    Article  CAS  PubMed  Google Scholar 

  24. Houldsworth J, Reuter V, Bosl GJ, Chaganti R (1997) Aberrant expression of cyclin D2 is an early event in human male germ cell tumorigenesis. Cell Growth Differ Mol Biol J Am Assoc Cancer Res 8(3):293–299

    CAS  Google Scholar 

  25. Huang Y-K, Huang Y-L, Hsueh Y-M et al (2008) Arsenic exposure, urinary arsenic speciation, and the incidence of urothelial carcinoma: a twelve-year follow-up study. Cancer Causes Control 19(8):829–839

    Article  PubMed  Google Scholar 

  26. Inskeep WP, Macur RE, Hamamura N, Warelow TP, Ward SA, Santini JM (2007) Detection, diversity and expression of aerobic bacterial arsenite oxidase genes. Environ Microbiol 9(4):934–943

    Article  CAS  PubMed  Google Scholar 

  27. Isokpehi RD, Udensi UK, Simmons SS et al (2014) Evaluative profiling of arsenic sensing and regulatory systems in the human microbiome project genomes. Microbiol Insights 7:25

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Jeng K-S, Chang C-F, Jeng W-J, Sheen I-S, Jeng C-J (2015) Heterogeneity of hepatocellular carcinoma contributes to cancer progression. Crit Rev Oncol Hematol 94(3):337–347

    Article  PubMed  Google Scholar 

  29. Karapetian RN, Evstafieva AG, Abaeva IS et al (2005) Nuclear oncoprotein prothymosin α is a partner of Keap1: implications for expression of oxidative stress-protecting genes. Mol Cell Biol 25(3):1089–1099

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Kile ML, Hoffman E, Rodrigues EG et al (2011) A pathway-based analysis of urinary arsenic metabolites and skin lesions. Am J Epidemiol 173(7):778–786

    Article  PubMed  PubMed Central  Google Scholar 

  31. Kim D, Langmead B, Salzberg SL (2015) HISAT: a fast spliced aligner with low memory requirements. Nat Methods 12(4):357–360

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Kubachka KM, Kohan MC, Conklin SD, Herbin-Davis K, Creed JT, Thomas DJ (2009) In vitro biotransformation of dimethylarsinic acid and trimethylarsine oxide by anaerobic microflora of mouse cecum analyzed by HPLC-ICP-MS and HPLC-ESI-MS. J Anal At Spectrom 24(8):1062–1068

    Article  CAS  Google Scholar 

  33. Kuo C-C, Moon KA, Wang S-L, Silbergeld E, Navas-Acien A (2017) The association of arsenic metabolism with cancer, cardiovascular disease and diabetes: a systematic review of the epidemiological evidence environmental health perspectives. Environ Health Perspect 87001:1

    Google Scholar 

  34. Kuroda K, Yoshida K, Yoshimura M et al (2004) Microbial metabolite of dimethylarsinic acid is highly toxic and genotoxic. Toxicol Appl Pharmacol 198(3):345–353

    Article  CAS  PubMed  Google Scholar 

  35. Lee YL, Xu X, Wallenstein S, Chen J (2009) Gene expression profiles of the one-carbon metabolism pathway. J Genet Genom 36(5):277–282

    Article  CAS  Google Scholar 

  36. Li X, Li B, Xi S, Zheng Q, Wang D, Sun G (2013) Association of urinary monomethylated arsenic concentration and risk of hypertension: a cross-sectional study from arsenic contaminated areas in northwestern China. Environ Health 12(1):37

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Lin Y-T, Chao CC-K (2015) Identification of the β-catenin/JNK/prothymosin-alpha axis as a novel target of sorafenib in hepatocellular carcinoma cells. Oncotarget 6(36):38999

    PubMed  PubMed Central  Google Scholar 

  38. Lindberg A-L, Kumar R, Goessler W et al (2007) Metabolism of low-dose inorganic arsenic in a central European population: influence of sex and genetic polymorphisms. Environ Health Perspect 115(7):1081

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Liu J, Waalkes MP (2008) Liver is a target of arsenic carcinogenesis. Toxicol Sci 105(1):24–32

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Liu M, Li Y, Chen L et al (2014) Allele-specific imbalance of oxidative stress-induced growth inhibitor 1 associates with progression of hepatocellular carcinoma. Gastroenterology 146(4):1084–1096.e5

    Article  CAS  PubMed  Google Scholar 

  41. Llovet JM, Bruix J (2008) Molecular targeted therapies in hepatocellular carcinoma. Hepatology 48(4):1312–1327

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Lu K, Cable PH, Abo RP et al (2013a) Gut microbiome perturbations induced by bacterial infection affect arsenic biotransformation. Chem Res Toxicol 26(12):1893–1903

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Lu L, Sun H-C, Zhang W et al (2013b) Aspirin minimized the pro-metastasis effect of sorafenib and improved survival by up-regulating HTATIP2 in hepatocellular carcinoma. PLoS One 8(5):e65023

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Lu K, Mahbub R, Cable PH et al (2014a) Gut microbiome phenotypes driven by host genetics affect arsenic metabolism. Chem Res Toxicol 27(2):172–174

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Lu K, Ryan PA, Schlieper KA et al (2014b) Arsenic exposure perturbs the gut microbiome and its metabolic profile in mice: an integrated metagenomics and metabolomics analysis. Environ Health Perspect 122(3):284–291

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Ma X, Shen D, Li H et al (2015) MicroRNA-185 inhibits cell proliferation and induces cell apoptosis by targeting VEGFA directly in von Hippel–Lindau-inactivated clear cell renal cell carcinoma. Urol Oncol-Semin Ori 33(4):169.e1–169.e11

    Article  CAS  Google Scholar 

  47. Magdalena C, Dominguez F, Loidi L, Puente J (2000) Tumour prothymosin alpha content, a potential prognostic marker for primary breast cancer. Br J Cancer 82(3):584

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Malicet C, Giroux V, Vasseur S, Dagorn JC, Neira JL, Iovanna JL (2006) Regulation of apoptosis by the p8/prothymosin α complex. Proc Natl Acad Sci USA 103(8):2671–2676

    Article  CAS  PubMed  Google Scholar 

  49. Naranmandura H, Ibata K, Suzuki KT (2007) Toxicity of dimethylmonothioarsinic acid toward human epidermoid carcinoma A431 cells. Chem Res Toxicol 20(8):1120–1125

    Article  CAS  PubMed  Google Scholar 

  50. Naujokas MF, Anderson B, Ahsan H et al (2013) The broad scope of health effects from chronic arsenic exposure: update on a worldwide public health problem. Environ Health Perspect 121(3):295

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Olano-Martin E, Mountzouris KC, Gibson GR, Rastall RA (2000) In vitro fermentability of dextran, oligodextran and maltodextrin by human gut bacteria. Br J Nutr 83(3):247–255

    Article  CAS  PubMed  Google Scholar 

  52. Pines J (1995) Cyclins, CDKs and cancer. Semin Cancer Biol 6(2):63–72

    Article  CAS  PubMed  Google Scholar 

  53. Pinyayev TS, Kohan MJ, Herbin-Davis K, Creed JT, Thomas DJ (2011) Preabsorptive metabolism of sodium arsenate by anaerobic microbiota of mouse cecum forms a variety of methylated and thiolated arsenicals. Chem Res Toxicol 24(4):475–477

    Article  CAS  PubMed  Google Scholar 

  54. Pu Y-S, Yang S-M, Huang Y-K et al (2007) Urinary arsenic profile affects the risk of urothelial carcinoma even at low arsenic exposure. Toxicol Appl Pharmacol 218(2):99–106

    Article  CAS  PubMed  Google Scholar 

  55. Qiao Y, Zhang Y, Wang J (2013) Ubiquitin E3 ligase SCF β-TRCP regulates TRIB2 stability in liver cancer cells. Biochem Biophys Res Commun 441(3):555–559

    Article  CAS  PubMed  Google Scholar 

  56. Rajilić-Stojanović M, Maathuis A, Heilig HG, Venema K, de Vos WM, Smidt H (2010) Evaluating the microbial diversity of an in vitro model of the human large intestine by phylogenetic microarray analysis. Microbiology 156(11):3270–3281

    Article  CAS  PubMed  Google Scholar 

  57. Rowland I, Davies M (1981) In vitro metabolism of inorganic arsenic by the gastro-intestinal microflora of the rat. J Appl Toxicol 1(5):278–283

    Article  CAS  PubMed  Google Scholar 

  58. Ruby MV, Davis A, Schoof R, Eberle S, Sellstone CM (1996) Estimation of lead and arsenic bioavailability using a physiologically based extraction test. Environ Sci Technol 30(2):422–430

    Article  CAS  Google Scholar 

  59. Sanz E, Muñoz-Olivas R, Cámara C (2005) A rapid and novel alternative to conventional sample treatment for arsenic speciation in rice using enzymatic ultrasonic probe. Anal Chim Acta 535(1):227–235

    Article  CAS  Google Scholar 

  60. Scott N, Hatlelid KM, MacKenzie NE, Carter DE (1993) Reactions of arsenic (III) and arsenic (V) species with glutathione. Chem Res Toxicol 6(1):102–106

    Article  CAS  PubMed  Google Scholar 

  61. Shi MM, Kugelman A, Iwamoto T, Tian L, Forman HJ (1994) Quinone-induced oxidative stress elevates glutathione and induces gamma-glutamylcysteine synthetase activity in rat lung epithelial L2 cells. J Biol Chem 269(42):26512–26517

    CAS  PubMed  Google Scholar 

  62. Shin HD, Park BL, Cheong HS, Yoon J-H, Kim YJ, Lee H-S (2007) SPP1 polymorphisms associated with HBV clearance and HCC occurrence. Int J Epidemiol 36(5):1001–1008

    Article  PubMed  Google Scholar 

  63. Sicinski P, Donaher JL, Geng Y, Parker SB (1996) Cyclin D2 is a FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature 384(6608):470

    Article  CAS  PubMed  Google Scholar 

  64. Song Y, Pan G, Chen L et al (2015) Loss of ATOH8 increases stem cell features of hepatocellular carcinoma cells. Gastroenterology 149(4):1068–1081.e5

    Article  CAS  PubMed  Google Scholar 

  65. Spiegelstein O, Lu X, Le XC et al (2005) Effects of dietary folate intake and folate binding protein-2 (Folbp2) on urinary speciation of sodium arsenate in mice. Environ Toxicol Pharmacol 19(1):1–7

    Article  CAS  PubMed  Google Scholar 

  66. Steinmaus C, Yuan Y, Kalman D et al (2010) Individual differences in arsenic metabolism and lung cancer in a case–control study in Cordoba, Argentina. Toxicol Appl Pharmacol 247(2):138–145

    Article  CAS  PubMed  Google Scholar 

  67. Sun G, Zhang J, Hu W (2014) CCNG2 expression is downregulated in colorectal carcinoma and its clinical significance. Tumor Biol 35(4):3339–3346

    Article  CAS  Google Scholar 

  68. Theriot CM, Bowman AA, Young VB (2016) Antibiotic-induced alterations of the gut microbiota alter secondary bile acid production and allow for Clostridium difficile spore germination and outgrowth in the large intestine. MSphere 1(1):e00045–e00015

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Thomas DJ (2007) Molecular processes in cellular arsenic metabolism. Toxicol Appl Pharmacol 222(3):365–373

    Article  CAS  PubMed  Google Scholar 

  70. Trapnell C, Williams BA, Pertea G et al (2010) Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 28(5):511–515

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Vahter M, Concha G (2001) Role of metabolism in arsenic toxicity. Basic Clin Pharmacol Toxicol 89(1):1–5

    Article  CAS  Google Scholar 

  72. Van de Wiele T, Gallawa CM, Kubachka KM et al (2010) Arsenic metabolism by human gut microbiota upon in vitro digestion of contaminated soils. Environ Health Perspect 118:1004–1009

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Waalkes MP, Ward JM, Diwan BA (2004) Induction of tumors of the liver, lung, ovary and adrenal in adult mice after brief maternal gestational exposure to inorganic arsenic: promotional effects of postnatal phorbol ester exposure on hepatic and pulmonary, but not dermal cancers. Carcinogenesis 25(1):133–141

    Article  CAS  PubMed  Google Scholar 

  74. Waalkes MP, Liu J, Diwan BA (2007) Transplacental arsenic carcinogenesis in mice. Toxicol Appl Pharmacol 222(3):271–280

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Wang J, Park J-S, Wei Y et al (2013) TRIB2 acts downstream of Wnt/TCF in liver cancer cells to regulate YAP and C/EBPα function. Mol Cell 51(2):211–225

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Wang W-Q, Liu L, Xu H-X et al (2014) The combination of HTATIP2 expression and microvessel density predicts converse survival of hepatocellular carcinoma with or without sorafenib. Oncotarget 5(11):3895

    PubMed  PubMed Central  Google Scholar 

  77. Wang J, Vasaikar S, Shi Z, Greer M, Zhang B (2017) WebGestalt 2017: a more comprehensive, powerful, flexible and interactive gene set enrichment analysis toolkit. Nucleic Acids Res 45(W1):W130–W137

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Wei B, Yu J, Wang J et al (2017) The relationships between arsenic methylation and both skin lesions and hypertension caused by chronic exposure to arsenic in drinking water. Environ Toxicol Pharmacol 53:89–94

    Article  CAS  PubMed  Google Scholar 

  79. Wibowo AS, Singh M, Reeder KM et al (2013) Structures of human folate receptors reveal biological trafficking states and diversity in folate and antifolate recognition. Proc Natl Acad Sci USA 110(38):15180–15188

    Article  PubMed  Google Scholar 

  80. Wu C, Habib N, Mitry R, Reitsma P, Van Deventer S, Chamuleau R (1997) Overexpression of hepatic prothymosin alpha, a novel marker for human hepatocellular carcinoma. Br J Cancer 76(9):1199

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Yu H, Liu S, Li M, Wu B (2016a) Influence of diet, vitamin, tea, trace elements and exogenous antioxidants on arsenic metabolism and toxicity. Environ Geochem Health 38(2):339–351

    Article  CAS  PubMed  Google Scholar 

  82. Yu H, Wu B, Zhang X-X et al (2016b) Arsenic metabolism and toxicity influenced by ferric iron in simulated gastrointestinal tract and the roles of gut microbiota. Environ Sci Technol 50(13):7189–7197

    Article  CAS  PubMed  Google Scholar 

  83. Zhang B, Kirov S, Snoddy J (2005) WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res 33(suppl_2):W741–W748

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Zhang H, Wang F, Hu Y (2017) STARD13 promotes hepatocellular carcinoma apoptosis by acting as a ceRNA for Fas. Biotechnol Lett 39(2):207–217

    Article  CAS  PubMed  Google Scholar 

  85. Zhao F, Yu J (2016) Unearthing a novel tumor suppressor function of ATOH8 in hepatocellular carcinoma: role in acquisition of cancer stem cell-like features. Transl Cancer Res 5(1):S91–S94

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank the NIH Grant (R01ES024950) for financial support for the project.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Kun Lu.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Chi, L., Xue, J., Tu, P. et al. Gut microbiome disruption altered the biotransformation and liver toxicity of arsenic in mice. Arch Toxicol 93, 25–35 (2019). https://doi.org/10.1007/s00204-018-2332-7

Download citation

Keywords

  • Gut bacteria
  • Microbiome
  • Arsenic biotransformation
  • Methylation
  • One-carbon metabolism